Presentation Information

[PO-008]CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CHINESE BIO-NAIVE PATIENTS WITH ULCERATIVE COLITIS, SUBGROUP RESULTS FROM 2ND INTERIM ANALYSIS OF VALUE STUDY

Hong Yang1, Ye Chen2, Haiyan Zhang3, Yingchao Li4, Xueli Ding5, Lifei Gu6, *Fang Zhou6, Minhu Chen7 (1. Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 100730, 2. Department of Gastroenterology, Integrated Clinical Microecology Center, Shenzhen Hospital, Southern Medical University, 1333 New Lake Road, Shenzhen, 518100, China., 3. Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China.510120, 4. The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 710000, 5. The Affiliated Hospital of Qingdao University, Qingdao, China. 266000, 6. Takeda Pharmaceutical Company, Shanghai, China. 200126, 7. The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China 510062)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in